A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B

Published:2010-12-30 Issue:4 Volume:4 Page:530-536
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut Liver

Author:

Shin Su Rin,Koh Kwang Cheol,Gwak Geum-Youn,Choi Moon Seok,Lee Joon Hyoek,Paik Seung Woon,Yoo Byung Chul

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2010/004/ekjg004-04-13.pdf

Reference32 articles.

1. EASL Clinical Practice Guidelines: Management of chronic hepatitis B

2. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

3. Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

4. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

5. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy;Intervirology;2014

2. Prolonged Combination Therapy is More Effective than Monotherapy in Management of Chronic Hepatitis B Patients With Sustained Virological Response: An Experience From a ‘Real-World’ Clinical Setting;Iranian Red Crescent Medical Journal;2013-12-05

3. Predictive Factors for Delayed Virologic Response of Adefovir Add-on Therapy in Lamivudine-resistant Chronic Hepatitis B;Soonchunhyang Medical Science;2013-06-25

4. Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B;Hepatology Research;2012-05-17

5. Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance;World Journal of Hepatology;2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3